<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34582277</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1486-3847</ISSN><JournalIssue CitedMedium="Internet"><Volume>82</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Canadian journal of dietetic practice and research : a publication of Dietitians of Canada = Revue canadienne de la pratique et de la recherche en dietetique : une publication des Dietetistes du Canada</Title><ISOAbbreviation>Can J Diet Pract Res</ISOAbbreviation></Journal><ArticleTitle>Blenderized Tube Feeding and Enterostomy Tube Occlusions Among Adults with Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>196</StartPage><EndPage>199</EndPage><MedlinePgn>196-199</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3148/cjdpr-2021-019</ELocationID><Abstract><AbstractText>Adults with amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS) may develop swallowing difficulties and elect to receive an enterostomy feeding tube for nutrition support. Blenderized tube feeding (BTF) appeals to those interested in a homemade enteral nutrition option, but there are concerns of feeding tube occlusion and limited research on this potential risk. Therefore, our purpose was to determine the frequency of, and risk factors for, feeding tube occlusions among adults with ALS or PLS who use BTF. For this retrospective study, the electronic medical records of tube-fed adults with ALS or PLS who received outpatient care at a provincial ALS clinic during a two-year period were reviewed (n&#x2009;=&#x2009;651). There were 97 tube-fed patients identified, of which 20 (21%) used BTF. Average duration of BTF use was 11.25&#x2009;&#xb1;&#x2009;7.5 months. Seven subjects (35%) used BTF exclusively, while 13 (65%) used a combination of BTF and commercial enteral formula. All received BTF by gastrostomy tube, sized 14 to 24 French. BTF administration methods and compliance with water flush recommendations varied. Despite the perceived risk of feeding tube occlusions with blenderized tube feeding, no occlusions were found to have occurred in this study.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kariya</LastName><ForeName>Claire</ForeName><Initials>C</Initials><Suffix>BSc, RD, CNSC</Suffix><AffiliationInfo><Affiliation>Vancouver Coastal Health Authority, Vancouver General Hospital, Department of Clinical Nutrition, Vancouver BC.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of British Columbia, Faculty of Land and Food Systems, Dietetics, Vancouver BC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vardi</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><Suffix>BSc, RD, CNSC</Suffix><AffiliationInfo><Affiliation>Vancouver Coastal Health Authority, GF Strong Rehabilitation Centre, ALS Centre, Vancouver BC.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Can J Diet Pract Res</MedlineTA><NlmUniqueID>9811151</NlmUniqueID><ISSNLinking>1486-3847</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004750" MajorTopicYN="N">Enteral Nutrition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004766" MajorTopicYN="Y">Enterostomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005774" MajorTopicYN="N">Gastrostomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="Y">Motor Neuron Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enteral nutrition</Keyword><Keyword MajorTopicYN="N">alimentation ent&#xe9;rale</Keyword><Keyword MajorTopicYN="N">amytrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">dysphagia</Keyword><Keyword MajorTopicYN="N">dysphagie</Keyword><Keyword MajorTopicYN="N">gastrostomie</Keyword><Keyword MajorTopicYN="N">gastrostomy</Keyword><Keyword MajorTopicYN="N">primary lateral sclerosis</Keyword><Keyword MajorTopicYN="N">scl&#xe9;rose lat&#xe9;rale amyotrophique</Keyword><Keyword MajorTopicYN="N">scl&#xe9;rose lat&#xe9;rale primaire</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>28</Day><Hour>17</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34582277</ArticleId><ArticleId IdType="doi">10.3148/cjdpr-2021-019</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>